Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye

NCT02101281 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DRUG: rhNGF 20 µg/mL
DRUG: rhNGF 4 µg/mL

Sponsor

Dompé Farmaceutici S.p.A

Collaborators

[object Object]